Informed Shared Decision making In Multiple Sclerosis immunotherapy (ISDIMS). A randomised controlled trial to investigate the effects of an evidence-based decision aid on decision-making about immunotherapy in multiple sclerosis.
Not Applicable
Completed
- Conditions
- Multiple sclerosis (MS)Nervous System Diseases
- Registration Number
- ISRCTN25267500
- Lead Sponsor
- niversity of Hamburg
- Brief Summary
2011 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/22043310 validation study 2008 Results article in https://pubmed.ncbi.nlm.nih.gov/19049552/ (added 27/10/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 297
Inclusion Criteria
Patients with multiple sclerosis who consider a new immunotherapy or who are willing to reconsider a decision (no selection of certain disease courses).
Exclusion Criteria
Patients with a major cognitive deficit and/or who do not agree to data check at health insurance companies are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method